Xuewei Cui

5.4k citations
37 papers · 3.8k · 4 hit papers · h-index 16

Impact in

Papers in

Xuewei Cui

35 papers receiving 3.7k citations

Hit Papers

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial 2021 · 648 citations
6480+2+5Years since publication2505007501000

Peers

Xuewei Cui
Comparison fields: 5 of 98
  • Endocrinology, Diabetes and Metabolism 2.9k
  • Pharmacology 1.2k
  • Endocrine and Autonomic Systems 261
  • Physiology 865
  • Surgery 1.1k
Replace Zvonko Miličević with:
Zvonko Miličević United States
Salvatore Calanna Denmark
Laura Fernández Landó United States
Jenny Han United States
Yukiko Onishi Japan
Kristin Taylor United States
Mark Kipnes United States
Carol Wysham United States
Mark Fineman United States
Klaus A. Dugi Germany
Xuewei Cui relative to Zvonko Miličević United States Zvonko Miličević's profile →
Citations per field
00.5×1.5×2.1×
Zvonko Miličević · 1×
Citations per year

Countries citing papers authored by Xuewei Cui

Since Specialization
Citations

This map shows the geographic impact of Xuewei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Cui more than expected).

Fields of papers citing papers by Xuewei Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Cui. The network helps show where Xuewei Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Xuewei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuewei Cui Line = papers co-authored together Xuewei Cui links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Hit paper breakdown →
20211112
2
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Hit paper breakdown →
2021648
3
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Hit paper breakdown →
2018610
4
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Hit paper breakdown →
2018603
5 2020220
6 2020171
7 202092
8 201575
9 202043
10 202337
11 201736
12 202132
13 201926
14 202218
15 202017
16 201717
17 202013
18 20228
19 20217
20 20206

About Xuewei Cui

Xuewei Cui is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Pharmacology, having authored 37 papers that have together received 3.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Metabolism, Diabetes, and Cancer (15 papers), Diabetes Management and Research (8 papers), Neonatal Respiratory Health Research (6 papers), Pharmacology and Obesity Treatment (5 papers), Congenital Diaphragmatic Hernia Studies (4 papers), Pancreatic function and diabetes (3 papers) and Gastrointestinal motility and disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.9k citations), Pharmacology (1.2k citations), Endocrine and Autonomic Systems (261 citations), Physiology (865 citations) and Surgery (1.1k citations). Xuewei Cui has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Juan P. Frías, Laura Fernández Landó, Julio Rosenstock, Axel Haupt, Katelyn Brown, Brandon K. Bergman, Melanie J. Davies, Federico C. Pérez Manghi, Bing Liu and Charles Benson. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Frontiers in Pediatrics, The Lancet and Clinical Pharmacokinetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact